Categories: NewsPharmaceutical

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, October 30, 2024, to provide a corporate update and discuss details of the Company’s financial results for the quarter ended September 30, 2024.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

Staff

Recent Posts

Brainomix Appoints Khush F. Mehta as Chair to Support Global Expansion and Commercial Growth

OXFORD, England and CHICAGO, May 21, 2025 /PRNewswire/ -- Brainomix, a global leader in AI-powered imaging…

19 minutes ago

The 10,000 Brains Project Launches the “Path-ND” Digital Brain Banking Program to Transform Neurodegenerative Disease Research

Funding from the Kissick Family Foundation Expands Frontotemporal Dementia Data; New Partnership with The Michael J. Fox Foundation Enhances Parkinson's Research OAKLAND, Calif., May…

6 hours ago

Medicus IT Names Roopak Manchanda as Executive Vice President of Community Health

Healthcare IT and community health leader to scale company's footprint and deepen impact in community-based…

6 hours ago

ESOC 2025: Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows

HELSINKI, May 20, 2025 /PRNewswire/ -- New research presented today at the European Stroke Organisation…

6 hours ago

Codoxo Creates New “Point Zero” Category in Payment Integrity: Pre-Claim Provider Education Reduces Abrasion While Saving Payers $12-16 PMPY

Codoxo's Point Zero approach creates an entirely new space in payment integrity—before claims are ever…

6 hours ago

Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants

Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Bloom Burton & Co. Inc. (Bloom Burton)…

11 hours ago